Gregor Diagnostics
- Total Funding
- $5.9M
- Last Round
- $900K SeedOct 2021
- Rounds
- 2
About
Molecular diagnostics company developing a novel screening test for prostate cancer using seminal fluid.
Summary
Gregor Diagnostics is a Biotech company. It has raised $5.9M in total across 2 rounds, most recently a $900K Seed round in Oct 2021. Investors include First Round Capital.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...